Dapoxetine Priligy Treatment of Premature Ejaculation
Please contact me if you are interested in any item.
Email: bob@pharmade.com
Skype: bob.pharmade
Also known as: Dapoxetina; Dapoxetinum; 119356-77-3; Dapoxetinum [INN-Latin]; Dapoxetina [INN-Spanish]; Dapoxetine hydrochloride; UNII-GB2433A4M3
Synonyms: d-Dapoxetine; DL-Dapoxetine
CAS: 119356-77-3
Assay: 98% min.
Packing: 1kg net/foil bag or tin.
Delivery: Express courier.
MF: C21H23NO.ClH
MW: 341.88
Character: White to Off-White Cyrstalline Solid, odorless, slight sweet taste.
Dapoxetine is a selective serotonin reuptake inhibitor, for the treatment of premature ejaculation. In a phase II proof-of-concept study conducted by PPD, dapoxetine demonstrated a statistically
significant increase in ejaculatory latency when compared to placebo. Alza submitted a NDA to the FDA for dapoxetine for the treatment of premature ejaculation in December 2004. In October 2005,
the company received a FDA Non-Approvable letter from the FDA, at which time they planned to work with regulators to address outstanding questions.